60 related articles for article (PubMed ID: 24820046)
1. Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial.
Chen L; Kim IK; Lane AM; Gauthier D; Munzenrider JE; Gragoudas ES; Miller JW
Br J Ophthalmol; 2014 Sep; 98(9):1212-7. PubMed ID: 24820046
[TBL] [Abstract][Full Text] [Related]
2. Proton beam irradiation for neovascular age-related macular degeneration.
Zambarakji HJ; Lane AM; Ezra E; Gauthier D; Goitein M; Adams JA; Munzenrider JE; Miller JW; Gragoudas ES
Ophthalmology; 2006 Nov; 113(11):2012-9. PubMed ID: 16935343
[TBL] [Abstract][Full Text] [Related]
3. Proton beam irradiation of subfoveal choroidal neovascularisation in age-related macular degeneration.
Flaxel CJ; Friedrichsen EJ; Smith JO; Oeinck SC; Blacharski PA; Garcia CA; Chu HH
Eye (Lond); 2000 Apr; 14 ( Pt 2)():155-64. PubMed ID: 10845009
[TBL] [Abstract][Full Text] [Related]
4. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
[TBL] [Abstract][Full Text] [Related]
5. [Radiation therapy of occult choroidal neovascularisation (CNV) in age-related macular degeneration (AMD)].
Weinberger AW; Wolf S; Kube T; Solbach U; Dobberstein H; Schleicher UM; Kirchhof B
Klin Monbl Augenheilkd; 1999 Feb; 214(2):96-9. PubMed ID: 10218202
[TBL] [Abstract][Full Text] [Related]
6. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study.
Marcus DM; Peskin E; Maguire M; Weissgold D; Alexander J; Fine S; Followill D;
Am J Ophthalmol; 2004 Nov; 138(5):818-28. PubMed ID: 15531318
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration.
Ophthalmology; 1999 Dec; 106(12):2239-47. PubMed ID: 10599652
[TBL] [Abstract][Full Text] [Related]
8. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy for choroidal neovascularization (CNV) in age-related macular degeneration (AMD)].
Thölen AM; Meister A; Bernasconi PP; Messmer EP
Klin Monbl Augenheilkd; 2000 Feb; 216(2):112-5. PubMed ID: 10730228
[TBL] [Abstract][Full Text] [Related]
10. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas.
Chan RV; Yonekawa Y; Lane AM; Skondra D; Munzenrider JE; Collier JM; Gragoudas ES; Kim IK
Ophthalmologica; 2010; 224(4):209-16. PubMed ID: 19940527
[TBL] [Abstract][Full Text] [Related]
11. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J
Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963
[TBL] [Abstract][Full Text] [Related]
12. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
14. Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration.
Essex RW; Tufail A; Bunce C; Aylward GW
Br J Ophthalmol; 2007 May; 91(5):649-54. PubMed ID: 17446505
[TBL] [Abstract][Full Text] [Related]
15. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration.
Avila MP; Farah ME; Santos A; Duprat JP; Woodward BW; Nau J
Br J Ophthalmol; 2009 Mar; 93(3):305-9. PubMed ID: 19019935
[TBL] [Abstract][Full Text] [Related]
16. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.
Merrill PT; LoRusso FJ; Lomeo MD; Saxe SJ; Khan MM; Lambert HM
Ophthalmology; 1999 Apr; 106(4):782-9. PubMed ID: 10201603
[TBL] [Abstract][Full Text] [Related]
17. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
[TBL] [Abstract][Full Text] [Related]
18. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
19. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
Tsai TH; Yang CM; Yang CH; Ho TC; Huang JS; Chen MS
Eye (Lond); 2007 Jun; 21(6):721-6. PubMed ID: 16543926
[TBL] [Abstract][Full Text] [Related]
20. Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration.
Unver YB; Yavuz GA; Bekiroğlu N; Presti P; Li W; Sinclair SH
Eye (Lond); 2009 Feb; 23(2):453-60. PubMed ID: 19039333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
